Expressed on the cell membrane of tumor-infiltrating lymphocytes (TIL), on activated CD4+ and CD8+ T cells, and on regulatory T cells (Treg), LAG-3 binds to MHC-II on APC. This evidence concerns the gene CD8A and neoplasm.